Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis
NCT01250665
·
clinicaltrials.gov ↗
UNKNOWN
Status
65
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Cognitive Impairment
Sponsor
Cantonal Hospital of St. Gallen
Collaborators
[object Object]